| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Reproductive Endocrinology |
Department of Pediatrics (H.S.B., W.L.M.) and the Metabolic Research Unit (W.L.M.), University of California San Francisco, San Francisco, California 94143; The Department of Pediatrics (O.H.P.), Indiana University Medical Center, Indianapolis, Indiana
Address all correspondence and requests for reprints to: Walter L. Miller, M.D., Department of Pediatrics, University of California, San Francisco, 1466 4th Avenue, Bldg MR-IV, Rm 209, San Francisco, California 94143-0978.
The most severe form of congenital adrenal hyperplasia (CAH) is lipoid CAH. It was once thought that this disease was due to mutations in the cholesterol side-chain cleavage enzyme system, thus eliminating the ability to convert cholesterol to pregnenolone, causing a complete absence of steroid hormone production. We recently showed that lipoid CAH is due to mutations in the steroidogenic acute regulatory (StAR) protein, thus preventing acutely stimulated adrenal and gonadal responses to tropic stimulation. However, this lesion may permit low levels of StAR-independent steroidogenesis to persist until the accumulation of intracellular lipid deposits destroys steroidogenic capacity. This model would predict that the steroidogenic cells of the ovaries of affected 46,XX females should remain undamaged until puberty, at which time low levels of StAR-independent estrogen biosynthesis should be detectable. We describe a 15.5-yr-old 46,XX female with a classic history of lipoid CAH who underwent spontaneous feminization and cyclical vaginal bleeding beginning at age 13. Genetic analysis of the patient and her parents showed that she was homozygous for the novel StAR frameshift mutation 261delT. This is the first adolescent female with lipoid CAH who has undergone spontaneous feminization and who has been analyzed genetically. Finding an inactive StAR gene in this patient confirms our two-hit model of the pathogenesis of lipoid CAH, in which loss of StAR activity initially preserves StAR-independent steroidogenesis, which is lost only after cells undergo chronic tropic stimulation and subsequent damage from accumulation of cholesterol esters.
This article has been cited by other articles:
![]() |
W. L. Miller StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import Mol. Endocrinol., March 1, 2007; 21(3): 589 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Y. Baker, L. Lin, C. J. Kim, J. Raza, C. P. Smith, W. L. Miller, and J. C. Achermann Nonclassic Congenital Lipoid Adrenal Hyperplasia: A New Disorder of the Steroidogenic Acute Regulatory Protein with Very Late Presentation and Normal Male Genitalia J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4781 - 4785. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nakatani, E. Hattori, T. Ohnishi, B. Dean, Y. Iwayama, I. Matsumoto, T. Kato, N. Osumi, T. Higuchi, S.-I. Niwa, et al. Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation Hum. Mol. Genet., June 15, 2006; 15(12): 1949 - 1962. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bhangoo, W.-X. Gu, S. Pavlakis, H. Anhalt, L. Heier, S. Ten, and J. L. Jameson Phenotypic Features Associated with Mutations in Steroidogenic Acute Regulatory Protein J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6303 - 6309. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Fluck, A. Maret, D. Mallet, S. Portrat-Doyen, J. C. Achermann, B. Leheup, G. E. Theintz, P. E. Mullis, and Y. Morel A Novel Mutation L260P of the Steroidogenic Acute Regulatory Protein Gene in Three Unrelated Patients of Swiss Ancestry with Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5304 - 5308. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, B. Y. Baker, M. A. Abduljabbar, and W. L. Miller A Genetic Isolate of Congenital Lipoid Adrenal Hyperplasia with Atypical Clinical Findings J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jo and D. M. Stocco Regulation of Steroidogenesis and Steroidogenic Acute Regulatory Protein in R2C Cells by DAX-1 (Dosage-Sensitive Sex Reversal, Adrenal Hypoplasia Congenita, Critical Region on the X Chromosome, Gene-1) Endocrinology, December 1, 2004; 145(12): 5629 - 5637. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Heikkila, H. Peltoketo, J. Leppaluoto, M. Ilves, O. Vuolteenaho, and S. Vainio Wnt-4 Deficiency Alters Mouse Adrenal Cortex Function, Reducing Aldosterone Production Endocrinology, November 1, 2002; 143(11): 4358 - 4365. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Coulter, I. C. McMillen, I. M. Bird, and M. D. Salkeld Steroidogenic Acute Regulatory Protein Expression Is Decreased in the Adrenal Gland of the Growth-Restricted Sheep Fetus During Late Gestation Biol Reprod, August 1, 2002; 67(2): 584 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Richmond, C. J. Flickinger, J. A. McDonald, M. A. Lovell, and A. D. Rogol Lipoid Congenital Adrenal Hyperplasia (CAH): Patient Report and a Mini-Review Clinical Pediatrics, July 1, 2001; 40(7): 403 - 407. [PDF] |
||||
![]() |
H. S. Bose, S. Sato, J. Aisenberg, S. A. Shalev, N. Matsuo, and W. L. Miller Mutations in the Steroidogenic Acute Regulatory Protein (StAR) in Six Patients with Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3636 - 3639. [Abstract] [Full Text] |
||||
![]() |
N. Katsumata, Y. Kawada, Y. Yamamoto, M. Noda, A. Nimura, R. Horikawa, and T. Tanaka A Novel Compound Heterozygous Mutation in the Steroidogenic Acute Regulatory Protein Gene in a Patient with Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3983 - 3987. [Abstract] [Full Text] |
||||
![]() |
J.-G. Lehoux, D. B. Hales, A. Fleury, N. Brière, D. Martel, and L. Ducharme The in Vivo Effects of Adrenocorticotropin and Sodium Restriction on the Formation of Different Species of Steroidogenic Acute Regulatory Protein in Rat Adrenal Endocrinology, November 1, 1999; 140(11): 5154 - 5164. [Abstract] [Full Text] |
||||
![]() |
H. S. Bose, R. M. Whittal, M. A. Baldwin, and W. L. Miller The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule PNAS, June 22, 1999; 96(13): 7250 - 7255. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Korsch, M. Peter, O. Hiort, W. G. Sippell, B. M. Ure, B. P. Hauffa, and M. Bergmann Gonadal Histology with Testicular Carcinoma in Situ in a 15-Year-Old 46,XY Female Patient with a Premature Termination in the Steroidogenic Acute Regulatory Protein Causing Congenital Lipoid Adrenal Hyperplasia J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1628 - 1632. [Abstract] [Full Text] |
||||
![]() |
E. Y. Adashi and J. D. Hennebold Single-Gene Mutations Resulting in Reproductive Dysfunction in Women N. Engl. J. Med., March 4, 1999; 340(9): 709 - 718. [Full Text] [PDF] |
||||
![]() |
J.-G. Lehoux, A. Fleury, and L. Ducharme The Acute and Chronic Effects of Adrenocorticotropin on the Levels of Messenger Ribonucleic Acid and Protein of Steroidogenic Enzymes in Rat Adrenal in Vivo Endocrinology, September 1, 1998; 139(9): 3913 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Miller Why Nobody Has P450scc (20,22 Desmoslase) Deficiencyg J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1399 - 1400. [Full Text] |
||||
![]() |
K. M. Caron, S.-C. Soo, W. C. Wetsel, D. M. Stocco, B. J. Clark, and K. L. Parker Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia PNAS, October 14, 1997; 94(21): 11540 - 11545. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |